Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.505 EUR | -5.64% | -21.61% | -1.31% |
Sales 2024 * | 10.6M 11.33M | Sales 2025 * | 6.95M 7.43M | Capitalization | 36.97M 39.53M |
---|---|---|---|---|---|
Net income 2024 * | -11M -11.76M | Net income 2025 * | -17M -18.18M | EV / Sales 2024 * | 5.09 x |
Net Debt 2024 * | 17M 18.18M | Net Debt 2025 * | 14M 14.97M | EV / Sales 2025 * | 7.33 x |
P/E ratio 2024 * |
-4.07
x | P/E ratio 2025 * |
-2.69
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.46% |
Latest transcript on Medigene AG
1 day | -5.64% | ||
1 week | -21.61% | ||
Current month | -28.67% | ||
1 month | -36.23% | ||
3 months | +4.15% | ||
6 months | -4.14% | ||
Current year | -1.31% |
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 22-07-24 |
Chief Tech/Sci/R&D Officer | - | 14-04-30 | |
Pamela Keck
IRC | Investor Relations Contact | - | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-08-11 | |
Frank Mathias
BRD | Director/Board Member | 62 | 18-05-14 |
Anthony Man
BRD | Director/Board Member | 68 | 20-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.505 | -5.64% | 44,837 |
24-04-25 | 1.595 | +0.31% | 12,206 |
24-04-24 | 1.59 | -7.56% | 42,373 |
24-04-23 | 1.72 | -10.42% | 114,079 |
24-04-22 | 1.92 | 0.00% | 3,487 |
Delayed Quote Xetra, April 26, 2024 at 11:36 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.31% | 39.46M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MDG1 Stock